Comparison of fluticasone/vilanterol vs fluticasone/salmeterol in stable copd patients
Not Applicable
- Conditions
- Health Condition 1: J40-J47- Chronic lower respiratory diseases
- Registration Number
- CTRI/2022/02/039895
- Lead Sponsor
- SRM college of pharmacy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
subjects with clinical history of moderate copd in accordance with the following definition by the european respiratory society.
subjects with measured FEV1/FVC ratio of 0.70 at screening.
subjects with measured FEVI 70% of predicted normal values.
patient willing to participate in the study and providing informed consent.
Exclusion Criteria
patients with <30 and >70 years of age and women of reproductive age (15-45 years).
patients with symptoms of acute exacerbation.
patients with uncontrolled diabetes mellitus and hypertension.
patients on immunosuppressive drugs.
patients with known trigger factors of asthma and malignancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method spirometry change <br/ ><br>complete blood countTimepoint: basal,14th day, 28th day,2nd month,3rd month.
- Secondary Outcome Measures
Name Time Method ST.George respiratory questionnaire.Timepoint: Baseline, 3rd month.